About WellGen
WellGen is a company based in North Brunswick (United States) founded in 1997. WellGen has raised $12.5 million across 2 funding rounds from investors including Amphion Innovations. WellGen operates in a competitive market with competitors including Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.
- Headquarter North Brunswick, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Wellgen, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$12.5 M (USD)
in 2 rounds
-
Latest Funding Round
$9.5 M (USD), Series C
Oct 29, 2007
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of WellGen
WellGen has successfully raised a total of $12.5M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $9.5 million completed in October 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in WellGen
WellGen has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Amphion Innovations.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech and life sciences focused VC firm investing in geographies such as the US and the UK
|
Locked | Locked | Locked |
Investor details for WellGen
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by WellGen
Investment portfolio details for WellGen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - WellGen
Detailed financials for WellGen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Wellgen Comparisons
Peer comparison for WellGen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of WellGen
WellGen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| Locked | Locked | Locked |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| Locked | Locked | Locked |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases are developed to treat patients.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| Locked | Locked | Locked |
Provider of cell therapies to treat cancer and hematologic conditions
|
Detailed competitors of WellGen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Wellgen
Complete news archive for WellGen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about WellGen
WellGen was founded in 1997 and raised its 1st funding round 9 years after it was founded.
WellGen is headquartered in North Brunswick, United States. It is registered at North Brunswick, New Jersey, United States.
WellGen is a funded company, having raised a total of $12.5M across 2 funding rounds to date.
Founded in 1997, WellGen operates in the nutrigenomics sector from North Brunswick, United States. Proprietary medical foods are created through in-house expertise in natural product chemistry and gene expression analysis. The Alignomxa bioinformatics model is utilized to identify optimal therapeutic areas for a pipeline of natural products. Opportunities in functional foods, beverages, and dietary supplements are also pursued.
WellGen's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
WellGen has 1 investor. Key investors include Amphion Innovations.